Effects of cyclosporine A on the hypothalamic-pituitary-adrenal axis and anterior pituitary interleukin-6 mRNA expression during chronic inflammatory stress in the rat

Journal of Neuroimmunology

Volumn 41, Issue 2, 1992, Pages 215-222

  Stephanou, A ^a   Sarlis, N J ^a   Knight, R A ^b   Lightman, S L ^a   Chowdrey, H S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Adjuvant arthritis; Adrenocorticotropin; Corticosterone; Cyclosporine A; Interleukin 6

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYCLOSPORIN A; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ARTHRITIS, EXPERIMENTAL; CHRONIC DISEASE; CORTICOTROPIN; CYCLOSPORINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; PITUITARY GLAND, ANTERIOR; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0026455093     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(92)90072-S     Document Type: Article

References (62)

1. Effects of in vivo treatments with cyclosporin A on mouse cell-mediated immune responses
2. Inhibition of T-cell activity by cyclosporin A
3. Blood and tissue distribution of cyclosporine in humans and mice
4. Cyclosporin treatment of a patient with severe systemic juvenile rheumatoid arthritis
5. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat
6. Biological effects of cyclosporin A: a new antilymphocytic agent
7. Immunopharmacological properties of cyclosporin and dihydrocyclosporin and their prospect in chronic inflammation
8. Interleukin-1 and interleukin-2 enhance proopiomelanocortin gene expression in the pituitary
9. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell response by impairing the release of interleukin 1 and interleukin 2
10. Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function
11. Cyclosporin A - a powerful immunosuppressant in dogs with renal allografts
12. Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin
13. Single-step method of RNA isolated by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Interleukin-1
15. Cyclosporin in rheumatoid arthritis: a double blind controlled study in 52 patients
16. Interleukin-1 as a stimulator of hormone secretion
17. Cyclosporin A as a sole immunosuppressive agent in recipient of kidney allografts from cadaver donors
18. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial
19. Iso-stimulation of GH and cAMP: comparison of β-adrenargic to CRF-stimulated GH release and cAMP accumulation in monolayer cultures of anterior pituitary cells in vitro
20. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate and glucocorticoids
21. Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog
22. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress
23. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat
24. Die Therapie der chronischen Polyarthritis mit Cyclosporin A, einem neuen Immunosuppressivum
25. Cyclosporin A. Mechanism of action: in vitro studies
26. Effects of cyclosporine on adrenocortical stress response of Wistar rats
27. Arthritis induced in rats by cloned T lymphocytes responsive to Mycobacteria but not to collagen type II
28. Osmotic regulation of hypothalamo-neurointermediate lobe corticotrophin-releasing factor-41 in the rat
29. Suppression of experimental allergic neuritis by cyclosporin-A
30. Cyclosporin-A: models for the mechanism of action
31. Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin
32. Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin secreting cells
33. The stimulatory effect of interleukin-6 on corticotropin releasing factor (CRF) and thyrotropin-releasing factor (TRF) secretion in vitro
34. The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A.
35. Mechanisms of action of cyclosporin A on islet α- and β-cells: effects on cAMP- and calcium-dependent pathways
36. Radioimmunoassay for plasma corticosterone
37. Interleukin-1 and -6 stimulate the release of corticotropin releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
38. Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones
39. Blood and tissue distribution of cyclosporin A after a single oral dose in the rat
40. Cyclosporin A blocks receptors for HLA-DR antigens on T cells
41. Development of arthritis periarthritis and periostitis in rats given adjuvant
42. Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide cyclosporin A
43. Cyclosporin inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes
44. Cyclosporin A treatment of experimental allergic encephalomyelitis: changes in immunological regulation and blood-CSF barrier function
45. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
46. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of diurnal rhythmicity during adjuvant-induced arthritis in the rat
47. Interleukin 1, tumor necrosis factor and interleukin 6 as mediators of cartilage destruction
48. Interleukin-6: an overview
49. Production of interleukin-6 by anterior pituitary cells in vitro
50. Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism
51. Response of pituitary and spleen proopiomelanocortin mRNA, and spleen and thymus interleukin-1β mRNA to adjuvant arthritis in the rat
52. Glucocorticoid-mediated responses of plasma adrenocorticotropin and anterior pituitary proopiomelanocortin growth hormone and prolactin mRNAs during adjuvant-induced arthritis in the rat
53. Interleukin-1 stimulates corticotropin releasing factor gene expression in the rat hypothalamus
54. The cellular basis of adjuvant arthritis
55. Cyclosporin-A inhibits lymphokine production but not the response of macrophages to lymphokines
56. Cyclosporine: immunology, toxicology and pharmacology in experimental animals
57. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor
58. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant II Evidence that the disease is a disseminated immunologic response to exogenous antigen
59. 2/B cell differentiation factor BSF2/hepatocyte stimulating factor gene in human fibroblasts by other cytokines
60. Corticotropin-releasing activity of monokines
61. 2-B cell stimulating factor) in human fibroblasts is supported by an increase in intracellular cyclic